Detalhe da pesquisa
1.
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
Mol Ther Nucleic Acids
; 4: e236, 2015 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-25872029
2.
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
Mol Ther Methods Clin Dev
; 1: 11, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-26015947
3.
CCR5 as a natural and modulated target for inhibition of HIV.
Viruses
; 6(1): 54-68, 2013 Dec 30.
Artigo
Inglês
| MEDLINE | ID: mdl-24381033